Decision Analysis: Applications in Orthopaedics Karim A. Meijer, - - PowerPoint PPT Presentation

decision analysis applications in orthopaedics
SMART_READER_LITE
LIVE PREVIEW

Decision Analysis: Applications in Orthopaedics Karim A. Meijer, - - PowerPoint PPT Presentation

Decision Analysis: Applications in Orthopaedics Karim A. Meijer, M.D. Joe Hahn, Ph.D., MBA and Jim Dyer, Ph. D. McCombs School of Business, UT Austin Analysis of Orthopaedic Treatment Decisions Three Applications: Patellar Resurfacing in


slide-1
SLIDE 1

Decision Analysis: Applications in Orthopaedics

Karim A. Meijer, M.D. Joe Hahn, Ph.D., MBA and Jim Dyer, Ph. D.

McCombs School of Business, UT Austin

slide-2
SLIDE 2

Analysis of Orthopaedic Treatment Decisions

§ Three Applications:

§ Patellar Resurfacing in Total Knee Replacements § Treatment of Clavicle “Collar Bone” Fractures § Surgical Treatment of Lisfranc Injuries

slide-3
SLIDE 3

Analysis of Orthopaedic Treatment Decisions

§ Gameplan

§ Introduction and Anatomy § Medical Literature Review and Data

§ Cost Estimates & Probabilities

§ Analysis and Results

§ Decision Tree and Sensitivity Analysis § PAYER PERSPECTIVE

§ Discussion/Questions

slide-4
SLIDE 4

Total Knee Replacement

§ Total Knee Arthroplasty (TKA) is a high volume procedure § Estimated to be 3.48 million per year in 2030 Kurtz et JBJS 2007 § ~600,000 performed in 2007 with costs exceeding $11 billon

Arch Intern Med. 2009

slide-5
SLIDE 5

Patellar Resurfacing

slide-6
SLIDE 6

Patella Resurfacing with TKA?

Physician (Provider): Government (Payer):

“Always, Sometimes, Never.”

27447 470

slide-7
SLIDE 7

TKA Resurfaced Patella Nonresurfaced Patella

Decision Tree Model

slide-8
SLIDE 8

Decision Tree Model

Resurfaced Patella Reoperations Instability Aseptic Loosening Fracture Ruptured Extensor Mechanism Other No Reoperations

slide-9
SLIDE 9

Decision Tree Model

Nonresurfaced Patella Reoperations Anterior Knee Pain Osteonecrosis Other No Further Operations

slide-10
SLIDE 10

Decision Tree Analysis

slide-11
SLIDE 11

Results

Resurfaced Nonresurfaced 5 Year Expected Cost $13,788.48 $14,016.41 Secondary Surgery 0.71% 3.34%

Cost Savings of $228 per knee More likely ~$750/knee

slide-12
SLIDE 12

No Resurface Resurface

Revision rates shown in Figure 1 .05 .1 .15 .2 .05 .1 .15 .2 Chance of Revision for not-Resurfaced

Two-way Sensitivity Analysis

Chance of Revision for Resurfaced

Sensitivity Analysis

slide-13
SLIDE 13

Discussion

§ Potential Savings

§ 15% Do not routinely resurface

§ AAHKS 2010 Survey

§ 2007 à $20,500,000/year § 2030 à $175,000,000/year (Medicare data)

§ Remember Payer’s Perspective!

slide-14
SLIDE 14

Clavicle “Collar Bone” Fractures

slide-15
SLIDE 15

Treatment of Clavicle Fractures

§ Background Data

§ 3-4% of all adult fractures § 80% occur in the middle 1/3 § Peak incidence in males under 30

§ Traditionally treated non-op

§ Retrospective data from 1960s

§ Low rates of nonunion (1%) § Included adolescents McKee et al. JBJS Am 2006 Neer JAMA 1960 Rowe CORR 1968

slide-16
SLIDE 16

Clavicle Fractures

§ New Study Results

§ Higher rates of nonunion (up to 15%) § Decreased patient satisfaction

§ Biomechanics § Advantages & Disadvantages § Trends

§ Synthes - domestic clavicle plate sales

§ 2009 - 11,630 Units § 2010 - 15,640 U (34% inc) § 2011 - 17,430 U (12% inc) § 2012 - 18,180 U (4.5% inc)

§ 2012- 56% inc over 2009

Hill et al. JBJS Br 1997 Ledger et al. JSES 2005

slide-17
SLIDE 17

Displaced Midshaft Clavicle Fracture Operative Treatment Nonoperative Treatment

Decision Tree Model

slide-18
SLIDE 18

Decision Tree Model

Operative Treatment Reoperations HWR HWR with I&D Revision ORIF Nonunion No Reoperations

slide-19
SLIDE 19

Decision Tree Model

Nonoperative Treatment Delayed Operative Procedure ORIF ORIF Malunion ORIF Nonunion No Further Operations

slide-20
SLIDE 20

Decision Tree Model

slide-21
SLIDE 21

Results

§ Decision tree analysis expected costs

§ Operative treatment- $14,763.21 § Nonoperative treatment- $3,112.65

§ Projected cost savings of $11,650.56/clavicle fracture

slide-22
SLIDE 22

Results

§ Sensitivity Analysis

§ 2-way analysis varying rates of reoperation and delayed operative treatment § Model remained stable over a wide range of probabilities

Non-OP treatment OP treatment x=.1871 y=.2348 .05 .1 .15 .2 .25 .2 .4 .6 .8 1 Probability of Delayed Surgery after non-OP Treatment

Two-way Sensitivity Analysis, Medicare Costs

slide-23
SLIDE 23

Discussion

§ Potential Savings

§ $11,650 per fracture

§ How many fractures are there?

§ Incidence 24-71 fractures / 100,000 population

§ Mueller J Trauma 2008 § Robison JBJS 1998

§ Let’s do the math…

§ US ~325,000,000 § 78,000 – 230,750 / per year § 80% occur in the midshaft § 62,400 – 184,600 fractures/year § $727 Million – $ 2.15 Billion in healthcare savings

slide-24
SLIDE 24

Lisfranc Injuries

slide-25
SLIDE 25

§ What’s the Big Deal?

§ Imperative to maintain normal foot biomechanics and function § Untreated injuries

§ Persistent pain § Progressive deformity § Prolonged disability

Lisfranc Injuries

slide-26
SLIDE 26

§ Surgery

§ Two Options

  • 1. Open Reduction Internal Fixation

(ORIF)

  • 2. Primary Arthrodesis

Lisfranc Injuries

slide-27
SLIDE 27

Surgical Treatment of Lisfranc Injuries

slide-28
SLIDE 28

Cost Estimation

§ Where you have your surgery matters!!!

§ Two decision tree models

§ Outpatient Hospital (APC) § Outpatient Ambulatory Surgery Center (ASC)

slide-29
SLIDE 29

Data

§ What Does the Literature Say?

slide-30
SLIDE 30

§ APC Expected Costs:

§ ORIF

§ $18,613

§ PA

§ $19,803

§ Expected Savings

§ $1,190

Basic Decision Tree Analysis

slide-31
SLIDE 31

§ ASC Expected Costs:

§ ORIF

§ $11,652

§ PA

§ $11,703

§ Expected Savings

§ $51

Basic Decision Tree Analysis

slide-32
SLIDE 32

Table 3 One-way Sensitivity Analysis Intersection Points Initial Cost/Percentage Indifference Point Percent Change

ORIF Cost APC $13,611.29 $14,801.80 (+) 8.7% ORIF Cost ASC $8,335.59 $8,387.12 (+) 0.62% Primary Arthrodesis Cost APC $18,165.50 $16,974.99 (-) 6.55% Primary Arthrodesis Cost ASC $10,662.66 $10,611.13 (-) 0.48% Probability of HWR after ORIF APC 60% 74% (+) 23.33% Probability of HWR after ORIF ASC 60% 61% (+) 1.67% HWR Cost ASC $3,394.82 $3,497.48 (+) 3.02% Probability of Secondary Surgery after PA ASC 17.65% 16.78% (-) 4.92%

Results

slide-33
SLIDE 33

Sensitivity Analysis: Costs

(+) $1,190.51 (+8.7%)

15000 16000 17000 18000 19000 20000 21000 22000 23000 $10,000.00 $11,000.00 $12,000.00 $13,000.00 $14,000.00 $15,000.00 $16,000.00 $17,000.00 $18,000.00

Expected Value

ORIF Cost

APC - ORIF Cost Variation

ORIF Primary Arthrodesis

PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin

15000 16000 17000 18000 19000 20000 21000 22000 23000 24000 25000 $13,000.00 $14,000.00 $15,000.00 $16,000.00 $17,000.00 $18,000.00 $19,000.00 $20,000.00 $21,000.00 $22,000.00 $23,000.00

Expected Value

Primary Arthrodesis Cost

APC - Primary Arthrodesis Cost Variation

ORIF Primary Arthrodesis

(-) $1,190.51 (-6.55%)

(+) $102.66 (+3.02%)

11000 11200 11400 11600 11800 12000 12200 $2,400.00 $2,600.00 $2,800.00 $3,000.00 $3,200.00 $3,400.00 $3,600.00 $3,800.00 $4,000.00 $4,200.00 $4,400.00

Expected Value

HWR Cost

ASC - HWR Cost Variation

ORIF Primary Arthrodesis

slide-34
SLIDE 34

Sensitivity Analysis: Probabilities

15000 16000 17000 18000 19000 20000 21000 22000 23000 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 110%

Expected Value Rate of HWR after ORIF

APC - Rate of HWR after ORIF

ORIF Primary Arthrodesis

60% à 74% (△ 23.33%) 17.65% à 16.78% (△ -4.92%)

11000 11200 11400 11600 11800 12000 12200 12400 5.00% 10.00% 15.00% 20.00% 25.00% 30.00%

Expected Value Rate of Secondary Surgery after Primary Arthrodesis

Rate of Secondary Surgery after Primary Arthrodesis

ORIF Primary Arthrodesis

slide-35
SLIDE 35

Two-Way Sensitivities

20% 30% 40% 50% 60% 70% 80% 90% 100% $10,000.00 $11,000.00 $12,000.00 $13,000.00 $14,000.00 $15,000.00 $16,000.00 $17,000.00 $18,000.00

Rate of HWR after ORIF

ORIF Cost

APC: ORIF Cost vs Rate of HWR after ORIF

ORIF Primary Arthrodesis

PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin

20% 30% 40% 50% 60% 70% 80% 90% 100% $6,000.00 $6,500.00 $7,000.00 $7,500.00 $8,000.00 $8,500.00 $9,000.00 $9,500.00 $10,000.00 $10,500.00

Rate of HWR after ORIF

ORIF Cost

ASC: ORIF Cost vs Rate of HWR after ORIF

ORIF Primary Arthrodesis

PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin

20% 30% 40% 50% 60% 70% 80% 90% 100% $7,000.00 $8,000.00 $9,000.00 $10,000.00 $11,000.00 $12,000.00 $13,000.00 $14,000.00

Rate of HWR after ORIF

Primary Arthrodesis Cost

ASC: Primary Arthrodesis Cost vs Rate of HWR after ORIF

ORIF Primary Arthrodesis

PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin PrecisionTree Course Version University of Texas Austin

slide-36
SLIDE 36

§ Sensitivity analyses reveals which inputs influence the decision policy § Outcomes can change with small differences in costs or probabilities

Lisfranc Treatment Analysis - Results

slide-37
SLIDE 37

Analysis of Orthopaedic Treatment Decisions

§ Three Applications:

§ Patellar Resurfacing in Total Knee Replacements § Treatment of Clavicle “Collar Bone” Fractures § Surgical Treatment of Lisfranc Injuries

slide-38
SLIDE 38

Conclusions

  • 1. Patella resurfacing during

primary TKA is the optimal financial strategy from a Medicare perspective over a mid term period.

slide-39
SLIDE 39

Conclusions

  • 2. Initial nonoperative management
  • f mid shaft clavicle fractures is

the optimal financial strategy from the payer perspective

slide-40
SLIDE 40

Conclusions

  • 3. Surgeon discretion is

the optimal surgical solution for each unique Lisfranc injury pattern

slide-41
SLIDE 41

Publications

slide-42
SLIDE 42

DISCUSSION & QUESTIONS

slide-43
SLIDE 43

Decision Analysis: Applications in Orthopaedics

Karim A. Meijer, M.D. kam@tsmog.com Joe Hahn, Ph.D, MBA and Jim Dyer, Ph.D.

McCombs School of Business, UT Austin